LIGAND PHARMACEUTICALS INC — Director's Dealing 2021

Jun 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2021-05-28

Reporting Person: FOEHR MATTHEW W (President and COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-28	Common Stock	G	2500	$0.0	Disposed	162600	Direct
2021-05-28	Common Stock	M	1755	$56.26	Acquired	164355	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-28	Employee Stock Option (right to buy)	$56.26	M	1755	Disposed	2025-02-10	Common Stock (1755)	Direct

Footnotes

F1: Charitable gift to a third party.

F2: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant was 02/10/15.